Health organizations agree that those who are undetectable can't transmit the virus, but researchers say the message isn't getting out.
Seventeen-year-old Samuel Weissman's research into HIV reservoirs could change the future of treatment.
Native Americans are addressing HIV within their community by reminding each other of their real names.
A massive Medicaid fraud ring is busted, which allegedly involved buying back HIV meds from impoverished patients and reselling them.
ViiV Healthcare makes progress in developing a monthly injectable to treat HIV.
Researchers say that GS-6207, Gilead's first-in-class capside inhibitor, can remain in our body's system for up to 24 weeks.
But the patient has remained free for just three months after ceasing treatment, making the results hopeful but not a cure.
